| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Independence Contract Drilling, Inc.
13D/A
ICDIQ · 453415606
|
0% |
1/22/2025
Event 1/17/2025
|
||||
| MSD Partners, L.P. | 0% | |||||
| MSD Credit Opportunity Master Fund, L.P. | 0% | |||||
| MSD PCOF Partners LXXIII, LLC | 0% | |||||
| MSD Private Credit Opportunity (NON-ECI) Fund, LLC | 0% | |||||
| Schedule 13G · 5 securities · passive | ||||||
|
ODDITY Tech Ltd.
13G
ODD · M7518J104
|
5.2% |
11/18/2026
Event 6/30/2026
|
||||
| MSD Partners, L.P. | 5.2% | |||||
| MSD Growth Fund, L.P. | 5.2% | |||||
| Byron D. Trott | 5.2% | |||||
|
Lindblad Expeditions Holdings, Inc.
13G/A
LIND · 535219109
|
4.99% |
5/15/2026
Event 3/31/2026
|
||||
| MSD Partners, L.P. | 2.5% | |||||
| MSD SIF Partners II, LLC | 0% | |||||
| Gregg R. Lemkau | 4.99% | |||||
|
Xponential Fitness, Inc.
13G/A
XPOF · 98422X101
|
4.7% |
2/17/2026
Event 12/31/2025
|
||||
| MSD Partners, L.P. | 4.7% | |||||
| MSD Credit Opportunity Master Fund, L.P. | 0.3% | |||||
| MSD Special Investments Fund, L.P. | 0.4% | |||||
| MSD SIF Holdings, L.P. | 0.2% | |||||
| MSD Special Investments Fund II, L.P. | 2.4% | |||||
| MSD SIF Holdings II, L.P. | 1.3% | |||||
| MSD Pcofmas2 SPV, LLC | 0% | |||||
| MSD Private Credit Opportunity Master Fund, L.P. | 0% | |||||
| MSD PCOF1 - BC, LLC | 0% | |||||
| MSD PCOF2 - BC2, LLC | 0% | |||||
| MSD PCOF1 - PC, LLC | 0% | |||||
| MSD Sbafla SPV, LLC | 0% | |||||
| Gregg R. Lemkau | 1.0% | |||||
| Byron D. Trott | 3.7% | |||||
|
Office Properties Income Trust
13G/A
OPITQ · 67623C109
|
0% |
8/13/2025
Event 6/30/2025
|
||||
| MSD Partners, L.P. | 0% | |||||
| MSD Special Investments Fund II, L.P. | 0% | |||||
| MSD SIF Holdings II, L.P. | 0% | |||||
| MSD RCOF Credit REIT, LLC | 0% | |||||
| MSD RCOF II Credit REIT, LLC | 0% | |||||
| MSD RCOF1 - PC, LLC | 0% | |||||
| MSD RCOF1 - BC, LLC | 0% | |||||
| MSD RCOF2 - PC2, LLC | 0% | |||||
| MSD RCOF2 - BC2, LLC | 0% | |||||
| MSD Credit Opportunity Master Fund, L.P. | 0% | |||||
| Gregg R. Lemkau | 0% | |||||
| Byron D. Trott | 0% | |||||
|
Alaunos Therapeutics, Inc.
13G/A
TCRT · 98973P309
|
0% |
2/13/2025
Event 12/31/2024
|
||||
| MSD Partners, L.P. | 0% | |||||
| MSD Credit Opportunity Master Fund, L.P. | 0% | |||||
| Gregg R. Lemkau | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.